Alzheimer’s risk could be lowered through beta-blockers

Researchers analysed the autopsies of 774 elderly Japanese-American men, 610 of whom were hypertensive or being treated with medication for high blood pressure.

Of the 350 men who were on medication, 15% were taking a beta-blocker alone, while 18% received a beta-blocker as part of  combination therapy.

Those who were on a beta-blocker monotherapy were found to have significantly fewer microinfarcts, less brain atrophy and fewer brain lesions indicating Alzheimer’s disease than those who were untreated and those who were on other anti